The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase 1 expansion trial of the LSD1 inhibitor seclidemstat (SP-2577) with and without topotecan and cyclophosphamide (TC) in patients (pts) with relapsed or refractory Ewing sarcoma (ES) and select sarcomas.
 
Damon R. Reed
Consulting or Advisory Role - Eisai; Pfizer
Travel, Accommodations, Expenses - Salarius Pharmaceuticals
 
Sant P. Chawla
Stock and Other Ownership Interests - AADi; Cellestia Biotech; Immix BioPharma
Honoraria - Advenchen Laboratories; Amgen; Bayer; CytRx Corporation; GlaxoSmithKline; Ignyta; Immune Design; InhibRx; Janssen; Karyopharm Therapeutics; NKMax; NKMax; Roche; SARC: Sarcoma Alliance for Research though Collaboration; Threshold Pharmaceuticals; TRACON Pharma; Tyme
Consulting or Advisory Role - Advenchen Laboratories; Amgen; Bayer; CytRx Corporation; GlaxoSmithKline; Ignyta; Immune Design; InhibRx; Janssen; Karyopharm Therapeutics; NKMax; Roche; SARC: Sarcoma Alliance for Research though Collaboration; Threshold Pharmaceuticals; TRACON Pharma
Speakers' Bureau - Amgen; CytRx Corporation; GlaxoSmithKline; Ignyta; Immune Design; Janssen; Karyopharm Therapeutics; Roche; SARC: Sarcoma Alliance for Research though Collaboration; Threshold Pharmaceuticals; TRACON Pharma
Research Funding - Advenchen Laboratories; Amgen; Bayer; CytRx Corporation; GlaxoSmithKline; Ignyta; Immune Design; InhibRx; Janssen; Janssen; Karyopharm Therapeutics; NKMax; Roche; SARC: Sarcoma Alliance for Research though Collaboration; Threshold Pharmaceuticals; TRACON Pharma
 
Bhuvana Setty
No Relationships to Disclose
 
Leo Mascarenhas
Consulting or Advisory Role - Bayer (Inst)
Speakers' Bureau - Bayer
Research Funding - Amgen (Inst); AstraZeneca/MedImmune (Inst); Bayer (Inst); Incyte (Inst); Lilly (Inst); Loxo (Inst); Pfizer (Inst); Salarius Pharmaceuticals (Inst); Turning Point Therapeutics (Inst)
Travel, Accommodations, Expenses - Bayer (Inst); Lilly (Inst); Salarius Pharmaceuticals; Thermo Fisher Scientific
(OPTIONAL) Uncompensated Relationships - American Society of Pediatric Hematology/Oncology; Children's Oncology Group Foundation; The Pablove Foundation
 
Paul A. Meyers
Stock and Other Ownership Interests - Amgen
Honoraria - Eastern Pulmonary Conference (I); France Foundation (I)
Consulting or Advisory Role - Boehringer Ingelheim (I); Salarius Pharmaceuticals
Speakers' Bureau - France Foundation (I); Genentech/Roche (I)
Travel, Accommodations, Expenses - InterMune (I); Takeda
 
Jonathan Metts
Research Funding - Celgene
 
Douglas James Harrison
No Relationships to Disclose
 
Stephen L. Lessnick
Leadership - Salarius Pharmaceuticals
Stock and Other Ownership Interests - Salarius Pharmaceuticals
Consulting or Advisory Role - Salarius Pharmaceuticals
Patents, Royalties, Other Intellectual Property - University of Utah
 
Brian D. Crompton
Employment - Acceleron Pharma (I); Mersana (I); Shire (I)
Stock and Other Ownership Interests - Acceleron Pharma (I); Mersana (I); Shire (I)
Research Funding - Gradalis
 
David Loeb
No Relationships to Disclose
 
David D. Stenehjem
Stock and Other Ownership Interests - Salarius Pharmaceuticals
Consulting or Advisory Role - Bristol-Myers Squibb; Dracen; Iterion Therapeutics; Molecular Templates; Salarius Pharmaceuticals
Research Funding - AstraZeneca (Inst); Bayer (Inst); Bioverativ (Inst); Bristol-Myers Squibb (Inst); Jazz Pharmaceuticals (Inst); Novartis (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
David S. Wages
Stock and Other Ownership Interests - iSpecimen
Consulting or Advisory Role - Acerta Pharma/AstraZeneca; Fujifilm; IQvia; Myovant Sciences; Salarius Pharmaceuticals
 
Daniela Y. Santiesteban
Employment - Salarius Pharmaceuticals
Stock and Other Ownership Interests - Salarius Pharmaceuticals; Salarius Pharmaceuticals (I)
 
Nadeem Q. Mirza
Employment - Salarius Pharmaceuticals; Verastem
Stock and Other Ownership Interests - Salarius Pharmaceuticals
 
Steven G. DuBois
Consulting or Advisory Role - Bayer
Research Funding - Bayer (Inst); BMS (Inst); Curis (Inst); Eisai (Inst); Lilly (Inst); Loxo (Inst); Merck (Inst); Pfizer (Inst); Roche/Genentech (Inst); Salarius Pharmaceuticals (Inst); Turning Point Therapeutics (Inst)
Travel, Accommodations, Expenses - Roche/Genentech; Salarius Pharmaceuticals
(OPTIONAL) Uncompensated Relationships - Ymabs Therapeutics Inc